Financial Information

IR Contact

M. Sc, CEO. Andreas Gerward

Andreas has during the last 10 years worked with pharmaceutical development in smaller companies. Since joining Stayble as the CEO in 2014 Andreas has developed the company from selection of the candidate drug through preclinical development and successful clinical trials. Andreas has an engineering background and a master’s in economics and Venture Creation from Chalmers University of Technology.

andreas.gerward@stayble.se +46 (0)730 808 397

Financial Calendar

ANNUAL REPORT 2023
17April2024
ANNUAL MEETING 2024
15May2024
INTERIM REPORT Q1 2024
21May2024
INTERIM REPORT Q2 2024
20August2024
INTERIM REPORT Q3 2024
29November2024
INTERIM REPORT Q4 2024
25February2025
Annual report 2024
7May2025
INTERIM REPORT Q1 2025
21May2025
Annual meeting 2025
5June2025
INTERIM REPORT Q2 2025
20August2025
INTERIM REPORT Q3 2025
19November2025
INTERIM REPORT Q4 2025
25February2026

IR Contact

M. Sc, CEO. Andreas Gerward

Andreas has during the last 10 years worked with pharmaceutical development in smaller companies. Since joining Stayble as the CEO in 2014 Andreas has developed the company from selection of the candidate drug through preclinical development and successful clinical trials. Andreas has an engineering background and a master’s in economics and Venture Creation from Chalmers University of Technology.

andreas.gerward@stayble.se +46 (0)730 808 397